Evidence map›Paper›PMID 41425495›Full record

Trial reportDrug design, development and therapy2025

The Effect of Opioid-Free Anesthesia with Esketamine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized, Controlled Trial.

Yuening Zhan, Zhaohui Liu, Song Meng, Mingze Luo, Zeqing Huang, Lingfei Wang

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuening Zhan *Department of Anesthesiology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, People's Republic of China.
Zhaohui Liu *Department of Anesthesiology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, People's Republic of China.ORCID 0000-0001-7246-7548
Song MengDepartment of Anesthesiology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, People's Republic of China.ORCID 0009-0008-2846-1921
Mingze LuoDepartment of Anesthesiology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, People's Republic of China.
Zeqing Huang *Department of Anesthesiology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, People's Republic of China.ORCID 0000-0003-1034-8118
Lingfei Wang *Department of Anesthesiology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, People's Republic of China.ORCID 0009-0005-5376-4551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Postoperative cognitive dysfunction (POCD) occurs at a higher rate in elderly patients undergoing thoracoscopic surgery, significantly affecting postoperative recovery and quality of life. However, effective interventions and anesthesia-related risk factors remain poorly understood. Purpose: This study aimed to evaluate the impact of esketamine-based opioid-free anesthesia (OFA) on POCD in elderly patients undergoing thoracoscopic lung cancer surgery. Patients and Methods: In this study, 80 elderly patients undergoing thoracoscopic lung cancer surgery were randomly allocated to receive either opioid-free anesthesia with esketamine (OFA group) or opioid-based anesthesia (Control group). The primary outcome was the incidence of POCD within 3 days. Logistic regression was used to identify risk factors for POCD. Results: The incidence of POCD was 20% and 42.5%, respectively, in the OFA group and the Control group (risk ratio [RR], 0.47; 95% confidence interval [CI], 0.24 to 0.92; risk difference [RD], -22.5%; 95% CI, -44.8% to -0.2%; p = 0.054). Compared to the Control group, patients in the OFA group had lower simple reaction time at 1 and 3 days post-surgery (1-day: p = 0.031; 3-day: p = 0.020). In addition, patients in the OFA group demonstrated higher mean values for mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), cardiac index (CI), stroke volume (SV), and systemic vascular resistance index (SVRI), as well as smaller variation ranges for these parameters, compared to the Control group (all p < 0.05), Furthermore, age (OR, 2.738; 95% CI, 1.37 to 6.30; p = 0.008), CO range (OR, 4.673; 95% CI, 2.25 to 11.82; p < 0.001), and time to first analgesic request (OR, 0.399; 95% CI, 0.18 to 0.76; p = 0.01) were validated to correlate with POCD. Conclusion: Esketamine-based OFA did not significantly reduce POCD incidence, and it was associated with improved postoperative reaction time and reduced intraoperative hemodynamic fluctuations.

Indexed as

AnesthesiaKetamineLung NeoplasmsPostoperative Cognitive ComplicationsThoracoscopyAgedAged, 80 and overAnalgesics, OpioidFemaleHumansMaleProspective StudiesAnalgesics, OpioidEsketamineKetamineesketaminehemodynamicsopioid-free anesthesiapostoperative cognitive dysfunctionthoracoscopic surgery

Identifiers

PMID41425495
PMCPMC12717858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.